Literature DB >> 23692208

Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.

Anders Helander1, Olof Beck, Robert Hägerkvist, Peter Hultén.   

Abstract

AIM: The study aimed to collect information concerning the increasing use of new psychoactive substances, commonly sold through online shops as 'Internet drugs' or 'legal highs', or in terms of masked products such as 'bath salts' and 'plant food'.
METHODS: The Karolinska Institutet and Karolinska University Laboratory and the Swedish Poisons Information Centre have initiated a project called 'STRIDA' aiming to monitor the occurrence and trends of new psychoactive substances in Sweden, and collect information about their clinical symptoms, toxicity and associated health risks. A liquid chromatographic-tandem mass spectrometric (LC-MS/MS) multi-component method has been developed, currently allowing for the determination of > 80 novel psychoactive compounds or metabolites thereof. This study focused mainly on the particular drug substances identified and the population demographics of the initial STRIDA cases.
RESULTS: In urine and/or blood samples obtained from 103 consecutive cases of admitted or suspected recreational drug intoxications in mostly young subjects (78% were ≤ 25 years, and 81% were males) presenting at emergency departments all over the country, psychoactive substances were detected in 82%. The substances comprised synthetic cannabinoids ('Spice'; JWH analogues), substituted cathinones ('bath salts'; e.g. butylone, MDPV and methylone) and tryptamines (4-HO-MET), plant-based substances (mitragynine and psilocin), as well as conventional drugs-of-abuse. In 44% of the cases, more than one new psychoactive substance, or a mixture of new and/or conventional drugs were detected.
CONCLUSION: The initial results of the STRIDA project have documented use of a broad variety of new psychoactive substances among mainly young people all over Sweden.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23692208     DOI: 10.3109/00365513.2013.793817

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  9 in total

1.  Fatalities associated with NPS stimulants in the Greater Cologne area.

Authors:  Sabrina Lehmann; Tobias Kieliba; Mario Thevis; Markus A Rothschild; Katja Mercer-Chalmers-Bender
Journal:  Int J Legal Med       Date:  2019-11-18       Impact factor: 2.686

2.  Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.

Authors:  Joseph J Palamar; Silvia S Martins; Mark K Su; Danielle C Ompad
Journal:  Drug Alcohol Depend       Date:  2015-09-03       Impact factor: 4.492

3.  Candyflipping and Other Combinations: Identifying Drug-Drug Combinations from an Online Forum.

Authors:  Michael Chary; David Yi; Alex F Manini
Journal:  Front Psychiatry       Date:  2018-04-30       Impact factor: 4.157

4.  Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.

Authors:  Joseph J Palamar; Mark K Su; Robert S Hoffman
Journal:  Am J Drug Alcohol Abuse       Date:  2015-12-17       Impact factor: 3.829

Review 5.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

6.  Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.

Authors:  Matilda Bäckberg; Luiza Tworek; Olof Beck; Anders Helander
Journal:  J Med Toxicol       Date:  2016-09-16

7.  Acute Intoxications Involving α-Pyrrolidinobutiophenone (α-PBP): Results from the Swedish STRIDA Project.

Authors:  Lisa Franzén; Matilda Bäckberg; Olof Beck; Anders Helander
Journal:  J Med Toxicol       Date:  2018-06-19

8.  Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.

Authors:  Anders Helander; Matilda Bäckberg; Olof Beck
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

9.  Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.

Authors:  Craig McKenzie; Oliver B Sutcliffe; Kevin D Read; Paul Scullion; Ola Epemolu; Daniel Fletcher; Anders Helander; Olof Beck; Alexia Rylski; Lysbeth H Antonides; Jennifer Riley; Shannah A Smith; Niamh Nic Daeid
Journal:  Forensic Toxicol       Date:  2018-04-05       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.